Zpam 1mg Tablet MD contains Clonazepam, a benzodiazepine derivative with potent anticonvulsant, anxiolytic, muscle relaxant, and sedative properties. It is primarily indicated for the management of seizure disorders, including absence seizures, myoclonic seizures, and Lennox-Gastaut syndrome, as well as for the treatment of panic disorder with or without agoraphobia. Clonazepam acts by enhancing the activity of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the central nervous system, thereby stabilizing neuronal membranes and reducing excitability. Zpam 1mg Tablet MD is administered orally, with dosage individualized based on the patient’s clinical condition, response to therapy, and tolerability. Caution is advised in patients with a history of substance abuse, respiratory insufficiency, hepatic impairment, or depression. Adverse effects may include drowsiness, dizziness, ataxia, cognitive impairment, and potential dependence with prolonged use. Abrupt discontinuation should be avoided to prevent withdrawal symptoms. This medication should be used under strict medical supervision, with regular monitoring to optimize therapeutic outcomes and minimize risks. Zpam 1mg Tablet MD is contraindicated in patients with hypersensitivity to benzodiazepines and should be used cautiously during pregnancy and lactation.